ELANCO ANIMAL HEALTH INC (ELAN) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:ELAN - US28414H1032 - Common Stock
22.6 USD
+0.22 (+0.98%)
22.6 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.411B -7.41% | 4.417B 0.14% | 4.439B 0.50% | 4.761B 7.25% | 5.034B 5.73% | 5.3B 5.28% | 5.53B 4.34% | 5.688B 2.86% | 5.803B 2.02% | 5.797B -0.10% | |
| EBITDA YoY % growth | 1.066B 4.51% | 1.02B -4.32% | 913M -10.49% | 919.36M 0.70% | 1.004B 9.21% | 1.1B 9.56% | 1.206B 9.64% | 1.258B 4.31% | 1.334B 6.04% | 2.085B 56.30% | |
| EBIT YoY % growth | 384M 26.32% | 326M -15.10% | 251M -23.01% | 712.03M 183.68% | 780.65M 9.64% | 870.77M 11.54% | 1.029B 18.17% | 1.077B 4.66% | 1.144B 6.22% | 1.301B 13.72% | |
| Operating Margin | 8.71% | 7.38% | 5.65% | 14.96% | 15.51% | 16.43% | 18.61% | 18.93% | 19.71% | 22.44% | |
| EPS YoY % growth | 1.11 5.71% | 0.89 -19.82% | 0.91 2.25% | 0.96 5.08% | 1.05 10.27% | 1.19 12.50% | 1.37 15.71% | 1.48 7.75% | 1.49 0.69% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.11 -19.28% | 0.36 -3.39% | 0.30 16.34% | 0.20 6.93% | 0.18 59.44% | 0.38 7.19% | 0.33 8.52% | 0.22 9.45% | 0.20 13.22% | 0.42 9.14% | 0.37 11.86% | 0.22 0.92% |
| Revenue Q2Q % growth | 1.114B 9.22% | 1.306B 9.47% | 1.339B 7.90% | 1.217B 7.04% | 1.17B 5.03% | 1.356B 3.83% | 1.405B 4.93% | 1.275B 4.77% | 1.223B 4.53% | 1.452B 7.08% | 1.511B 7.54% | 1.361B 6.75% |
| EBITDA Q2Q % growth | 181.61M -72.89% | 314.7M 11.60% | 278.63M -32.86% | 211.24M -60.37% | 195.2M 7.48% | 330.12M 4.90% | 298.22M 7.03% | 227.52M 7.71% | 205.44M 5.25% | N/A | N/A | N/A |
| EBIT Q2Q % growth | 141.42M 1,667.75% | 280.11M 131.50% | 242.67M 185.49% | 175.07M 548.41% | 159.36M 12.69% | 304.43M 8.68% | 261.42M 7.73% | 187.5M 7.10% | 159.18M -0.11% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.19 46.15% | 0.13 | 0.06 | 42.93% |
| Q2 2025 Q2Q % growth | 0.26 -13.33% | 0.20 | 0.06 | 30.48% |
| Q1 2025 Q2Q % growth | 0.37 8.82% | 0.32 | 0.05 | 17.01% |
| Q4 2024 Q2Q % growth | 0.14 75.00% | 0.15 | -0.01 | -8.70% |
| Q3 2024 Q2Q % growth | 0.13 -27.78% | 0.12 | 0.01 | 7.92% |
| Q2 2024 Q2Q % growth | 0.30 66.67% | 0.25 | 0.05 | 22.24% |
| Q1 2024 Q2Q % growth | 0.34 -24.44% | 0.27 | 0.07 | 26.41% |
| Q4 2023 Q2Q % growth | 0.08 -57.89% | 0.11 | -0.03 | -26.01% |
| Q3 2023 Q2Q % growth | 0.18 -10.00% | 0.12 | 0.06 | 48.43% |
| Q2 2023 Q2Q % growth | 0.18 -50.00% | 0.05 | 0.13 | 269.34% |
| Q1 2023 Q2Q % growth | 0.45 25.00% | 0.29 | 0.16 | 53.01% |
| Q4 2022 Q2Q % growth | 0.19 -9.52% | 0.13 | 0.06 | 45.19% |
| Q3 2022 Q2Q % growth | 0.20 5.26% | 0.16 | 0.04 | 23.32% |
| Q2 2022 Q2Q % growth | 0.36 28.57% | 0.26 | 0.10 | 38.95% |
| Q1 2022 Q2Q % growth | 0.36 -2.70% | 0.36 | 0.00 | -0.02% |
| Q4 2021 Q2Q % growth | 0.21 75.00% | 0.17 | 0.04 | 20.26% |
| Q3 2021 Q2Q % growth | 0.19 46.15% | 0.17 | 0.02 | 12.71% |
| Q2 2021 Q2Q % growth | 0.28 211.11% | 0.27 | 0.01 | 4.51% |
| Q1 2021 Q2Q % growth | 0.37 184.62% | 0.23 | 0.14 | 59.86% |
| Q4 2020 Q2Q % growth | 0.12 -47.83% | 0.09 | 0.03 | 34.67% |
| Q3 2020 Q2Q % growth | 0.13 -56.67% | 0.12 | 0.01 | 5.33% |
| Q2 2020 Q2Q % growth | 0.09 -67.86% | 0.06 | 0.03 | 57.34% |
| Q1 2020 Q2Q % growth | 0.13 -48.00% | 0.24 | -0.11 | -46.39% |
| Q4 2019 Q2Q % growth | 0.23 | 0.23 | 0.00 | -1.78% |
| Q3 2019 Q2Q % growth | 0.30 | 0.26 | 0.04 | 14.81% |
| Q2 2019 Q2Q % growth | 0.28 | 0.26 | 0.02 | 7.27% |
| Q1 2019 Q2Q % growth | 0.25 | 0.23 | 0.02 | 6.73% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.137B 10.39% | 1.114B | 23M | 2.06% |
| Q2 2025 Q2Q % growth | 1.241B 4.81% | 1.211B | 30M | 2.48% |
| Q1 2025 Q2Q % growth | 1.193B -1.00% | 1.192B | 1M | 0.08% |
| Q4 2024 Q2Q % growth | 1.02B -1.45% | 1.03B | -10M | -0.97% |
| Q3 2024 Q2Q % growth | 1.03B -3.56% | 1.055B | -25M | -2.37% |
| Q2 2024 Q2Q % growth | 1.184B 12.02% | 1.174B | 10M | 0.85% |
| Q1 2024 Q2Q % growth | 1.205B -4.14% | 1.198B | 7M | 0.58% |
| Q4 2023 Q2Q % growth | 1.035B 5.50% | 1.022B | 13M | 1.27% |
| Q3 2023 Q2Q % growth | 1.068B 4.09% | 1.06B | 8M | 0.75% |
| Q2 2023 Q2Q % growth | 1.057B -10.04% | 1.056B | 1M | 0.09% |
| Q1 2023 Q2Q % growth | 1.257B 2.61% | 1.202B | 55M | 4.58% |
| Q4 2022 Q2Q % growth | 981M -11.78% | 1.001B | -20M | -2.00% |
| Q3 2022 Q2Q % growth | 1.026B -9.28% | 1.053B | -27M | -2.56% |
| Q2 2022 Q2Q % growth | 1.175B -8.13% | 1.205B | -30M | -2.49% |
| Q1 2022 Q2Q % growth | 1.225B -1.37% | 1.244B | -19M | -1.53% |
| Q4 2021 Q2Q % growth | 1.112B -2.23% | 1.125B | -13M | -1.16% |
| Q3 2021 Q2Q % growth | 1.131B 27.14% | 1.105B | 26M | 2.35% |
| Q2 2021 Q2Q % growth | 1.279B 118.15% | 1.267B | 12M | 0.95% |
| Q1 2021 Q2Q % growth | 1.242B 88.84% | 1.183B | 59M | 4.99% |
| Q4 2020 Q2Q % growth | 1.137B 44.52% | 1.078B | 59.4M | 5.51% |
| Q3 2020 Q2Q % growth | 889.6M 15.34% | 927.52M | -37.92M | -4.09% |
| Q2 2020 Q2Q % growth | 586.3M -24.99% | 601.22M | -14.92M | -2.48% |
| Q1 2020 Q2Q % growth | 657.7M -10.04% | 732.78M | -75.08M | -10.25% |
| Q4 2019 Q2Q % growth | 787M | 807.33M | -20.33M | -2.52% |
| Q3 2019 Q2Q % growth | 771.3M | 780.73M | -9.43M | -1.21% |
| Q2 2019 Q2Q % growth | 781.6M | 798.54M | -16.94M | -2.12% |
| Q1 2019 Q2Q % growth | 731.1M | 758.4M | -27.3M | -3.60% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.19% | -15.37% | 3.77% | 5.66% |
| Revenue | 0% | 1.55% | 1.41% | 1.58% |